|1.||Nicol, Mark P: 18 articles (08/2015 - 01/2010)|
|2.||Dheda, Keertan: 18 articles (08/2015 - 01/2011)|
|3.||Kaufmann, Stefan H E: 18 articles (08/2015 - 11/2007)|
|4.||Kaplan, Gilla: 18 articles (01/2015 - 11/2003)|
|5.||Ehrt, Sabine: 17 articles (09/2015 - 10/2003)|
|6.||Zumla, Alimuddin: 17 articles (09/2015 - 03/2009)|
|7.||Theron, Grant: 17 articles (08/2015 - 07/2011)|
|8.||Mayanja-Kizza, Harriet: 17 articles (07/2015 - 01/2008)|
|9.||Boom, W Henry: 16 articles (01/2015 - 08/2003)|
|10.||Cho, Sang-Nae: 15 articles (11/2015 - 01/2010)|
11/01/2012 - "Herein, we have characterized a rabbit model of LTBI in which, similar to most humans, complete clearance of pulmonary Mtb infection and pathological characteristics occurs spontaneously. "
01/01/2010 - "Analyses of the ICL knockdown mutant in single-strain infections confirmed this and demonstrated that silencing of ICL during chronic infections impaired persistence of Mtb to the extent that the pathogen was cleared from the lungs of most mice."
04/01/2015 - "Administration of Rpfd2 mutant enhanced Th1-type cellular responses (IFN-γ and IL-2) in mice (P < 0.05, Rpfd2 versus control) and provided effective protection against Mtb in mice by significantly inhibiting the growth of Mtb during the initial stage of infection. "
01/01/2015 - "However, significant distinctions in the disease pathology and host genome-wide lung transcriptome suggest improved containment of Mtb infection in animals vaccinated with the bfrB mutant, compared to BCG. "
08/01/2015 - "More importantly, mice with acute infection benefited a lot from a single-dose administration of this vaccine by markedly reduced MTB burdens in lungs and spleens as well as attenuated lesions in lungs compared with untreated mice. "
02/01/2014 - "Thus, exploring the molecular characteristics of MTB is helpful for understanding and controlling the spread of strains in areas with a high incidence of tuberculosis. "
01/01/2015 - "Thus, this novel method is shown to improve the detection limit and specificity of MTB from the sputum samples, and to reduce the testing time for accurate diagnosis of tuberculosis, which needs further confirmation of more clinical samples."
07/01/2014 - "This review summarizes the intricate network of TLR2-mediated signaling and Mycobacteria effectors involved in MTB-host interaction with an aim to find better target for improved tuberculosis control, especially the host-derived therapy targets. "
10/01/2007 - "Comparison between the two HIV groups also suggested better S-Mtb responses in those cured from tuberculosis. "
12/01/2015 - "Currently available tuberculosis (TB) drugs while effective in killing actively growing MTB, is largely ineffective in killing persistent or latent MTB. "
01/01/2015 - "Mycobacterium bovis bacillus Calmette-Guerin (BCG), the only licensed vaccine, shows limited protection efficacy against pulmonary tuberculosis (TB), particularly hypervirulent Mycobacterium tuberculosis (Mtb) strains, suggesting that a logistical and practical vaccination strategy is urgently required. "
11/01/2014 - "Diagnostics such as Xpert MTB/RIF may help to determine pulmonary tuberculosis prevalence, however its performance in severely malnourished children is largely unknown. "
08/01/1998 - "Although the identity of T cells involved in the protection against Mycobacterium tuberculosis (Mtb) in humans remain unknown, patients with pulmonary tuberculosis (TB) have reduced numbers of Mtb-reactive, V gamma 9+/V delta 2+ T cells in their blood and lungs. "
11/01/2015 - "The Xpert(®) MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania."
04/01/2015 - "This prospective, multi-centre study evaluated the performance of Xpert MTB/RIF to diagnose pulmonary tuberculosis in children. "
01/01/2011 - "This study aimed to evaluate the value of detection of the genome of Mycobacterium tuberculosis (MTB) by polymerase chain reaction (PCR) method for the diagnosis of tuberculous pleurisy and compare the results with those of conventional methods. "
11/01/2015 - "Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples."
10/01/2015 - "[Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay]."
01/01/2015 - "Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens."
11/01/2014 - "Pleural tuberculosis (PLTB), a major cause of morbidity and mortality, is the most common extrapulmonary manifestation of active Mycobacterium tuberculosis (Mtb) in developing countries. "
|5.||Extensively Drug-Resistant Tuberculosis
05/01/2015 - "Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country."
01/01/2015 - "Surveillance of the clinical isolates of MTB is recommended to strengthen the identification of MDR/XDR TB and sublineages of the Beijing/W strains."
10/17/2014 - "Long treatment times, poor drug compliance, and natural selection during treatment of Mycobacterium tuberculosis (Mtb) have given rise to extensively drug-resistant tuberculosis (XDR-TB). "
01/01/2014 - "The potential of the surfactant in the therapy of human cavitary TB was also investigated using a surgically removed lung from a patient with extreme drug resistant MTB (XDR-TB). "
01/01/2014 - "All (n=9) MTB strains resistant to four or five first line drugs and Extensively drug resistant (XDR-TB) strains were from foreign-born cases. "
|3.||DNA (Deoxyribonucleic Acid)
|4.||Biological Markers (Surrogate Marker)
|6.||Proteins (Proteins, Gene)
|9.||Interleukin-10 (Interleukin 10)
|1.||Drug Therapy (Chemotherapy)
|3.||Transplantation (Transplant Recipients)
|5.||Highly Active Antiretroviral Therapy (HAART)